Crescent Capital BDC (CCAP) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Apr, 2026Executive summary
Q4 2025 net investment income was $0.45 per share, down from $0.46 in Q3, with net income per share rising to $0.23 from $0.19 sequentially, and NAV per share declined to $19.10 from $19.28.
Board declared a Q1 2026 regular dividend of $0.42 per share, payable April 15, 2026.
Portfolio remains diversified and fundamentally healthy, with 184 companies across 18 industries and strong sponsor support.
Management is reviewing fee structure and dividend policy to ensure long-term earnings durability amid lower rate expectations.
Portfolio is defensively positioned, with 91% in senior secured first lien and unitranche first lien investments.
Financial highlights
Net investment income covered the base dividend by 107% in Q4.
Total assets at quarter-end were $1.62 billion, with total net assets of $706 million.
Debt-to-equity ratio stood at 1.25x, with net debt-to-equity at 1.20x, both within target range.
Investment portfolio at fair value totaled $1.569 billion across 184 companies.
Weighted average yield on income-producing securities at cost was 10.0%, with 98% of debt investments floating rate.
Outlook and guidance
Management expects to provide a more detailed update on strategic actions and dividend policy in May 2026.
Board and management are proactively adapting to a lower rate environment to maintain earnings stability.
Portfolio positioned defensively, with strong liquidity: $31.5 million in cash and $242 million undrawn debt capacity.
Long-term outlook for private credit remains favorable, with disciplined underwriting and active management.
Latest events from Crescent Capital BDC
- Virtual meeting to elect directors and ratify auditor, with online voting available.CCAP
Proxy filing1 Apr 2026 - Virtual meeting to elect directors and ratify E&Y as auditor, with strong governance oversight.CCAP
Proxy filing1 Apr 2026 - Q2 2024 NII reached $0.59/share, NAV $20.30, with strong liquidity and stable credit.CCAP
Q2 20241 Feb 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the 2025 annual meeting agenda.CCAP
Proxy Filing2 Dec 2025 - Stockholders will vote virtually on director elections and auditor ratification, with strong board oversight.CCAP
Proxy Filing2 Dec 2025 - Net investment income and NAV per share fell, but dividends and portfolio quality remain strong.CCAP
Q1 202526 Nov 2025